Kura Oncology (KURA) Reports In-Line Q4 EPS

Kura Oncology (NASDAQ: KURA) reported Q4 EPS of ($0.55), in-line with the analyst estimate of ($0.55).

For earnings history and earnings-related data on Kura Oncology (KURA) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity